Stanley Lapidus - Sep 20, 2022 Form 4 Insider Report for Lucid Diagnostics Inc. (LUCD)

Role
Director
Signature
/s/ Stanley Lapidus
Stock symbol
LUCD
Transactions as of
Sep 20, 2022
Transactions value $
-$57,683
Form type
4
Date filed
9/22/2022, 11:46 AM
Previous filing
Feb 23, 2022
Next filing
Feb 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUCD Common stock Sale -$29K -17K -10.04% $1.71 152K Sep 20, 2022 Direct F1, F2
transaction LUCD Common stock Sale -$28.7K -16.9K -11.07% $1.70 135K Sep 20, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock.
F2 Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which will vest September 20, 2023. Under the plan, unvested shares are subject to forfeiture if the requisite service period is not completed.